RxDoctor Payments Data

Anna Bahnson, MD

Dermatology · Sioux Falls, SDNPI 1073177853

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 28.2% of the total. Reporting peaked in 2023 at $1,155 and has fallen 60.8% since, to $453 in 2025.

$2,297in general payments, 2019–2025

Across 58 payments — averaging $39.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$649
  • Sanofi$389
  • Novartis$223
  • Incyte Corporation$205
  • Boehringer Ingelheim$193
  • Johnson & Johnson$170
  • plus $469 from 8 others

What the payments were for

  • Food & beverage$2,21797%
  • Education$803%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,297 in reported general payments places this provider in the 70th percentile of 44 dermatology providers in South Dakota.

See all dermatology providers in South Dakota

Medicare billing

Part B allowed, 2024
$63,840
Medicare patients
396
Services billed
1,437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab42$149,276
Clobetasol Propionate57$2,752
Fluorouracil37$2,667
Ketoconazole92$1,679
Tacrolimus11$1,255
Hydroxychloroquine Sulfate11$728
Fluocinonide18$594
Doxycycline Hyclate18$588
Triamcinolone Acetonide42$477
Doxycycline Monohydrate18$448
Naltrexone Hcl14$261
Mupirocin39$239
Hydrocortisone31$201
Prednisone13$76
Terbinafine Hcl12$58

Paid to pharmacies, not to this prescriber.

Other dermatology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →